Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Poultry Science
|
July 4, 2020
Effects of a partially perforated flooring system on animal-based welfare indicators in broiler housing
C Adler, I Tiemann, S Hillemacher, et al.
Journal of Cancer Research and Clinical Oncology
|
May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro
Joseph Kauer, Melanie Märklin, Martin Pflügler, et al.
Frontiers in Immunology
|
May 1, 2023
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer
Martina S Lutz, Latifa Zekri, Laura Weßling, et al.
Cancers
|
September 26, 2020
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia
Claudia Tandler, Moritz Schmidt, Jonas S Heitmann, et al.
Scientific Reports
|
December 5, 2019
CD105 (Endoglin) as negative prognostic factor in AML
Joseph Kauer, Karolin Schwartz, Claudia Tandler, et al.
BMC Cancer
|
June 6, 2026
B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples
Linus D Kloker, Robert Rottscholl, Jonas S Heitmann, et al.
Diagnostics (Basel, Switzerland)
|
November 27, 2021
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
Kübra Kaban, Sarah M Greiner, Samuel Holzmayer, et al.
Cancers
|
December 11, 2019
Induction of NK Cell Reactivity against B-Cell Acute Lymphoblastic Leukemia by an Fc-Optimized FLT3 Antibody
Bastian J Schmied, Martina S Lutz, Fabian Riegg, et al.
Cancers
|
December 10, 2021
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course
Kim L Clar, Lisa M Weber, Bastian J Schmied, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2022
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
Martina Svenja Lutz, Boris Klimovich, Stefanie Maurer, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Poultry Science
|
July 4, 2020
Effects of a partially perforated flooring system on animal-based welfare indicators in broiler housing
C Adler, I Tiemann, S Hillemacher, et al.
Journal of Cancer Research and Clinical Oncology
|
May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitro
Joseph Kauer, Melanie Märklin, Martin Pflügler, et al.
Frontiers in Immunology
|
May 1, 2023
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer
Martina S Lutz, Latifa Zekri, Laura Weßling, et al.
Cancers
|
September 26, 2020
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia
Claudia Tandler, Moritz Schmidt, Jonas S Heitmann, et al.
Scientific Reports
|
December 5, 2019
CD105 (Endoglin) as negative prognostic factor in AML
Joseph Kauer, Karolin Schwartz, Claudia Tandler, et al.
BMC Cancer
|
June 6, 2026
B7-H3 membranous expression correlates with histological grading in a two-center cohort of 133 pre-treatment bone and soft tissue sarcoma samples
Linus D Kloker, Robert Rottscholl, Jonas S Heitmann, et al.
Diagnostics (Basel, Switzerland)
|
November 27, 2021
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
Kübra Kaban, Sarah M Greiner, Samuel Holzmayer, et al.
Cancers
|
December 11, 2019
Induction of NK Cell Reactivity against B-Cell Acute Lymphoblastic Leukemia by an Fc-Optimized FLT3 Antibody
Bastian J Schmied, Martina S Lutz, Fabian Riegg, et al.
Cancers
|
December 10, 2021
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course
Kim L Clar, Lisa M Weber, Bastian J Schmied, et al.
Journal for Immunotherapy of Cancer
|
February 3, 2022
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
Martina Svenja Lutz, Boris Klimovich, Stefanie Maurer, et al.
Page
of 8